AlphaFold predicted structure
FXYD2 · P54710

Mean pLDDT
75.6/ 100
Confident
66 residues
Confidence breakdown
- Very high(≥ 90)38%
- Confident(70–90)14%
- Low(50–70)46%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
FXYD domain containing ion transport regulator 2
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Renal tubulopathies
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedLikely inborn error of metabolism
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownUndiagnosed metabolic disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknowncongestive heart failure
atrial fibrillation
heart failure
renal hypomagnesemia 2
cardiovascular disorder
Autosomal dominant primary hypomagnesemia with hypocalciuria
Arrhythmia
type 2 diabetes mellitus
neurodegenerative disease
Supraventricular tachycardia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Sodium/potassium-transporting ATPase subunit gamma
May be involved in forming the receptor site for cardiac glycoside binding or may modulate the transport function of the sodium ATPase
FXYD2 · P54710

Mean pLDDT
75.6/ 100
Confident
66 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0